Developing the Society of Obstetric Medicine Australia and New Zealand (SOMANZ) Hypertension in Pregnancy Guideline 2023: Guideline development approaches, challenges and contextual considerations
Renuka Shanmugalingam, Zachary Munn, Timothy H. Barker, Helen L. Barrett, Amanda Beech, Lucy Bowyer, Tim Crozier, Amanda Davidson, Marloes Dekker Nitert, Aunty Kerrie Doyle, Luke Grzeskowiak, Nicole Hall, Hicham Cheikh Hassan, Annemarie Hennessy, Amanda Henry, David Langsford, Vincent W. Lee, Michael Peek, Joanne M. Said, Helen Tanner, Rachel Taylor, Meredith Ward, Jason Waugh, Linda Yen, Ellie Medcalf, Katy Bell, Deonna Ackermann, Robin Turner, Angela Makris
{"title":"Developing the Society of Obstetric Medicine Australia and New Zealand (SOMANZ) Hypertension in Pregnancy Guideline 2023: Guideline development approaches, challenges and contextual considerations","authors":"Renuka Shanmugalingam, Zachary Munn, Timothy H. Barker, Helen L. Barrett, Amanda Beech, Lucy Bowyer, Tim Crozier, Amanda Davidson, Marloes Dekker Nitert, Aunty Kerrie Doyle, Luke Grzeskowiak, Nicole Hall, Hicham Cheikh Hassan, Annemarie Hennessy, Amanda Henry, David Langsford, Vincent W. Lee, Michael Peek, Joanne M. Said, Helen Tanner, Rachel Taylor, Meredith Ward, Jason Waugh, Linda Yen, Ellie Medcalf, Katy Bell, Deonna Ackermann, Robin Turner, Angela Makris","doi":"10.1002/gin2.70000","DOIUrl":null,"url":null,"abstract":"<p>The Society of Obstetric Medicine Australia and New Zealand (SOMANZ) Hypertension in Pregnancy Guideline 2023 is the first evidence-based guideline for hypertensive disorders of pregnancy that has been developed to the standards of the Australian National Health and Medical Research Council (NHMRC). This article describes the methodology, challenges and considerations in developing the guideline and includes details on group composition, literature search, evidence synthesis and development of recommendations. We also discuss several practical considerations and challenges related to contextual issues, topics of interest and resources available for guideline developers working with similar jurisdictions or topics.</p>","PeriodicalId":100266,"journal":{"name":"Clinical and Public Health Guidelines","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gin2.70000","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Public Health Guidelines","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/gin2.70000","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The Society of Obstetric Medicine Australia and New Zealand (SOMANZ) Hypertension in Pregnancy Guideline 2023 is the first evidence-based guideline for hypertensive disorders of pregnancy that has been developed to the standards of the Australian National Health and Medical Research Council (NHMRC). This article describes the methodology, challenges and considerations in developing the guideline and includes details on group composition, literature search, evidence synthesis and development of recommendations. We also discuss several practical considerations and challenges related to contextual issues, topics of interest and resources available for guideline developers working with similar jurisdictions or topics.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
